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The articles by Orr and colleagues1 and Lettieri and Williams2
superbly highlight the complexities of managing posttraumatic
stress disorder (PTSD) and comorbid obstructive sleep apnea
(OSA) and underline the sometimes bidirectional nature of the
relationship between OSA and some PTSD symptoms.3 Orr
and colleagues1 examined the effect of positive airway pressure
(PAP) therapy in veterans with PTSD and recently diagnosed
OSA and noticed a modest improvement in PTSD severity as
measured by the PTSD Checklist-Specific (PCL-S), from baseline to 6 months. There was a significant decrease (albeit below
the minimum threshold to qualify as a response to treatment)
in PCL-S scores from baseline to 3 months, with no significant
change from 3 to 6 months. Only the percentage of nights that
PAP was used (and not average hours or percentage nights with
more than 4 hours of use) was predictive of improvement in
PCL-S scores. These results are consistent with the decrease
in sympathetic activation with PAP therapy,4 which likely improved some PTSD symptoms.
The modest improvement in PTSD symptoms with continuous positive airway pressure underlines the possible contribution of hyperarousal and high levels of sympathetic activation
in PTSD, that can cause sleep fragmentation1,2 and increased
upper airways collapsibility and OSA in patients with PTSD3
that is often unrecognized. I have treated several patients with
PTSD and OSA with anticonvulsant mood stabilizers such
as divalproex sodium (dosage 750–1500 mg/d) for emotional
regulation, because of poor response to standard pharmacotherapies for PTSD (such as antidepressants). Most of these patients were nonadherent to PAP therapy. The apnea-hypopnea
index (AHI) in these patients (measured with serial home sleep
testing or HST) sometimes decreased from the severe range
(AHI > 30 events/h) to mild to moderate range (< 10 events/h)
after a 10- to 14-day course of divalproex. The improvement in AHI was associated with a significant improvement
in sleep fragmentation (increased sleep efficiency and total
sleep time, decreased number of arousals per hour, decreased
sleep onset latency) and clinically significant improvement in
PTSD symptoms. The adjunctive use of mood stabilizers in

the management of patients with OSA, PTSD, high levels of
baseline sympathetic activation, and sleep fragmentation merits further investigation.
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